About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Tomosynthesis in the Oslo Breast Cancer Screening Program

NCT01248546·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Oslo University Hospital

With

Norwegian Institute of Public Health
Hologic, Inc.

Age

50–69

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

Women 50 to 69 years who have signed the informed consent

You may not be if

Women with pacemaker, implants, and severely disabled

The record

StatusUnknown

PhaseNo phase

Taking part25,000

StartedNov 2010

UpdatedFeb 5, 2013

Conditions

Recall Rate Cancer Detection Rate False Positive Rate Positive Predictive Value

Where1

Oslo University Hospital, Ulleval
Oslo, Oslo, Norway

Clareo Health | Tomosynthesis in the Oslo Breast Cancer Screening Program